Give with Group Elite

The Group Elite team has a special connection with a young girl who has directly benefited from the Retinoblastoma Program at The Hospital for Sick Children (SickKids). Retinoblastoma is a rare but devasting form of childhood cancer affecting the retina at the back of eye. Treatments are designed to kill the tumour cells and to preserve vision as much as possible. Group Elite is supporting the STEP-RB clinical trial led by Dr. Brenda Gallie, Ophthalmologist & Vision Science Department at SickKids. Positive results from the study could be a step toward new treatment options for patients with retinoblastoma.